Compounds derived from cyclohexylamine, beta2 agonists and antagonists of Muscarinic m3； Intermediate Compounds, Pharmaceutical Composition and Method for treating Physiological condition or illness； and combination Product comprising the composition and a corticosteroid or inhiidor PDE4.
The present invention relates to novel compounds having ²2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.COMPUESTOS DERIVADOS DE CICLOHEXILAMINA, AGONISTAS ß2 Y ANTAGONISTAS MUSCARÍNICOS M3； COMPOSICIÓN FARMACÉUTICA； Y PRODUCTO DE COMBINACIÓN QUE COMPRENDE AL COMPUESTO Y A UN CORTICOSTEROIDE O UN INHIBIDOR DE PDE4； Y SU USO PARA TRATAR ENFERMEDADES PULMONARES, PARTO PREMATURO, GLAUCOMA, TRASTORNOS NEUROLÓGICOS, TRASTORNOS CARDIACOS, INFLAMACIÓN, TRASTORNOS GASTROINTESTINALES, ASMA O EPOC.
